AT468098T
Topical stabilized prostaglandin e compound dosage forms
Abstract
(PGE the compound) is stable and non-water composition's prostaglandin TRACK types of compounds, the composition comprises a compound and a pantoprazole, wherein the pantoprazole can be the fool-proofing water liquid or piece, the film or a powder form fixing. The composition can be optionally comprising a reducing of potentiator. Non-water solid dosage-form comprising basically are an of the supporting the PGE compounds of sheet or thin film.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
45 members in 18 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 33648103 | United States of America | A | |
| 33648103 | United States of America | A | |
| 0341658 | United States of America | W | |
| 0341658 | United States of America | W | |
| 336481 | – | – | – |
| 0341658 | – | – | – |
| US20030336481 | – | – | – |
| WO2003US41658 | – | – | – |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| US2004131664A1 | United States of America | A1 | |
| CA2512015A1 | Canada | A1 | |
| WO2004062632A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003300113A1 | Australia | A1 | |
| US6841574B2 | United States of America | B2 | |
| US2005181030A1 | United States of America | A1 | |
| KR20050098853A | Republic of Korea | A | |
| EP1585483A1 | European Patent Office (EPO) | A1 | |
| BR0317924A | Brazil | A | |
| CN1756532A | China | A | |
| EP1585483A4 | European Patent Office (EPO) | A4 | |
| ZA200505321B | South Africa | B | |
| JP2006514068A | Japan | A | |
| AU2006204069A1 | Australia | A1 | |
| CA2592978A1 | Canada | A1 | |
| WO2006074204A2 | World Intellectual Property Organization (WIPO) | A2 | |
| HK1090293A | Hong Kong, China | A | |
| HK1090293A1 | Hong Kong, China | A1 | |
| WO2006074204A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20070094836A | Republic of Korea | A | |
| IL184322A0 | Israel | A0 | |
| EP1855648A2 | European Patent Office (EPO) | A2 | |
| MX2007008325A | Mexico | A | |
| CN101132763A | China | A | |
| JP2008526854A | Japan | A | |
| ZA200705516B | South Africa | B | |
| CN100574763C | China | C | |
| AU2003300113B2 | Australia | B2 | |
| EP1585483B1 | European Patent Office (EPO) | B1 | |
| AT468098TThis record | Austria | T | |
| ATE468098T1 | Austria | T1 | |
| PT1585483E | Portugal | E | |
| DE60332656D1 | Germany | D1 | |
| DK1585483T3 | Denmark | T3 | |
| ES2343246T3 | Spain | T3 | |
| IL169425A | Israel | A | |
| KR20110042138A | Republic of Korea | A | |
| CA2512015C | Canada | C | |
| JP2012036196A | Japan | A | |
| KR101174788B1 | Republic of Korea | B1 | |
| EP1855648A4 | European Patent Office (EPO) | A4 | |
| CA2592978C | Canada | C | |
| KR20140006083A | Republic of Korea | A | |
| JP5395138B2 | Japan | B2 | |
| JP2014055144A | Japan | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 468098
- Publication, EPODOC
- AT468098T
- Application
- 3800371
- Application, DOCDB
- 03800371
- Application, EPODOC
- AT20030800371T
Titles2
- German
- TOPISCHE STABILISIERTE DOSIERUNGSFORMEN FÜR PROSTAGLANDIN E-VERBINDUNGEN
- English
- TOPICAL STABILIZED DOSAGE FORMS FOR PROSTAGLANDIN E COMPOUNDS
Classification
- CPC, 13
- A61K9/7007
- A61K9/00
- A61K9/0034
- A61K31/557
- A61K31/5575
- Y10S514/947
- A61P1/04
- Y10S514/953
- A61P3/00
- A61P15/08
- A61P9/00
- A61P15/10
- A61P17/02
- IPC, 9
- A61K8 00
- A61F13 00
- A61K9 00
- A61K9 14
- A61K9 70
- A61K31 19
- A61K31 557
- A61K31 5575
- A61L15 16